Cresemba

Active Ingredient(s): Isavuconazonium Sulfate
FDA Approved: * March 6, 2015
Pharm Company: * ASTELLAS
Category: Antifungal

Isavuconazonium sulfate, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis.[7][5][6][9] The most common side effects include abnormal liver tests, nausea, vomiting, difficulty breathing, abdominal pain, diarrhea, injection site reactions, headache, low blood potassium and skin rash.[8] Isavuconazonium is a pr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cresemba 186 mg Oral Capsule

NDC: 0469-0320

Labeler:

Astellas Pharma Us, Inc.

Cresemba 74.4 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution

NDC: 0469-0420

Labeler:

Astellas Pharma Us, Inc.

Cresemba 186 mg Oral Capsule

NDC: 0469-0520

Labeler:

Astellas Pharma Us, Inc.

Cresemba 40 mg Oral Capsule

NDC: 0469-2860

Labeler:

Astellas Pharma Us, Inc.